Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5593062 | 0.75 | TXNRD1 (0.37) | TDP1ALDH1A1MEN1KMT2ATDP2 | |
| SCHEMBL8779774 | 0.74 | ALDH1A1 (0.36) | TDP1ALDH1A1HSD17B10CDC25BHSP90AA1 | |
| SCHEMBL330028 | 0.73 | BLM (0.35) | TDP1MEN1KMT2ATDP2NSD2 | |
| SCHEMBL29435677 | 0.71 | TRPV4 (0.51) | TDP1ALDH1A1HSD17B10TRPV4MEN1 | |
| SCHEMBL349118 | 0.71 | TRPV4 (0.51) | TDP1ALDH1A1HSD17B10TRPV4MEN1 | |
| SCHEMBL6968378 | 0.71 | TDP2 (0.33) | TDP1MEN1KMT2ATDP2NSD2 | |
| SCHEMBL4847957 | 0.71 | TDP2 (0.33) | TDP1MEN1KMT2ATDP2NSD2 | |
| SCHEMBL4062075 | 0.71 | HSP90AA1 (0.38) | TDP1ALDH1A1TRPV4MEN1KMT2A | |
| SCHEMBL27303298 | 0.71 | TRIM24 (0.34) | TDP1MEN1KMT2ATDP2NSD2 | |
| SCHEMBL51141 | 0.71 | CA1 (0.43) | TDP1HSD17B10MEN1KMT2ATDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912662-A | Epoxy resin curing agent for insulating castable and preparation method thereof | 江苏三木化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119912663-A | Epoxy resin curing agent for corrosion prevention of stripping tower and preparation method thereof | 江苏三木化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-110668952-B | Preparation method of benzphetamine hydrochloride | 安徽贝克制药股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-110642721-B | Preparation method of selegiline hydrochloride | 安徽贝克生物制药有限公司 | 2022-09-30 | — | — | CN | claimed |
| CN-110668952-A | Preparation method of benzphetamine hydrochloride | 安徽贝克联合制药有限公司 | 2020-01-10 | — | — | CN | claimed |
| CN-110642721-A | Preparation method of selegiline hydrochloride | 安徽贝克生物制药有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-107602566-B | The synthetic method of florasulam intermediate | JIANGSU AGRICULTURAL HORMONE ENGINEERING TECHNOLOGY RESEARCH CENTRE CO., LTD. (CN) | 2019-11-01 | — | — | CN | claimed |
| CN-107602566-A | The synthetic method of florasulam intermediate | 江苏省农用激素工程技术研究中心有限公司 | 2018-01-19 | — | — | CN | claimed |
| CN-1039590-A | Alkoxy-1, 2, 4-triazolo [1, 5-C ] pyrimidine-2-sulfonamides, processes for their preparation and intermediates | DOW CHEMICAL CO (US) | 1990-02-14 | — | — | CN | claimed |
| CN-119912662-A | Epoxy resin curing agent for insulating castable and preparation method thereof | 江苏三木化工股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119912663-A | Epoxy resin curing agent for corrosion prevention of stripping tower and preparation method thereof | 江苏三木化工股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-20250101003-A1 | SPIROCYCLIC CAV2.3 ANTAGONISTS | LARIO THERAPEUTICS LIMITED (GB) | 2025-03-27 | — | — | US | disclosed |
| CN-113490668-B | Compounds and compositions for the treatment of diseases associated with APJ receptor activity | 安娜普尔纳生物股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20240336590-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY | ANNAPURNA BIO, INC. | 2024-10-10 | — | — | US | disclosed |
| CN-1071429-A | The N-aryl-1,2 that replaces, the preparation method of 4-triazolo pyrimidine-2-sulphonamide | DOWELANCO (US) | 1993-04-28 | — | — | CN | disclosed |
| CN-1068824-A | N-pyrazolyl-1, 2, 4-triazolo [1, 5-c ] pyrimidine-2-sulfonamides as herbicides | DOWELANCO (US) | 1993-02-10 | — | — | CN | disclosed |
| EP-0375076-A1 | Heterocyclic herbicides | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1990-06-27 | — | — | EP | disclosed |
| CN-87103145-A | Weedicide | — | 1988-05-11 | — | — | CN | disclosed |
| US-4256888-A | Preparation of 2-chloropyrimidines | EASTMAN KODAK COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| US-4128586-A | Catalytic reduction of aromatic sulfonyl halides with hydrogen sulfide to yield aromatic thiols | ALLIED CHEMICAL CORPORATION (US) | 1978-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336590-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY | APLNR, AGTR1, AGTR2 | TDP1 3499/4885ALDH1A1 2778/4885HSD17B10 1493/4885 |
| US-20250101003-A1 | SPIROCYCLIC CAV2.3 ANTAGONISTS | CACNA1A, CACNA1E, CACNA1S | TDP1 3390/4885ALDH1A1 2756/4885HSD17B10 4042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.